1 / 3

Post Herpetic Neuralgia Treatment Market Prevalent Opportunities upto 2026

Growing cases of post herpetic neuralgia treatment are increasing the number of referrals to pain management clinics resulting in growth of market. According to a latest research by Persistence Market Research (PMR), the global post herpetic neuralgia treatment market is anticipated to account for over US$ 908.4 Mn, in terms of value, by 2026 end. The report on post herpetic neuralgia treatment further projects significant growth potential of post herpetic neuralgia treatment market with CAGR pegged at 5.3% through 2026.<br><br>For Detailed Insights On Enhancing Your Product Footprint, Request For A Sample Here @ https://www.persistencemarketresearch.com/samples/14506

Manoj7645
Télécharger la présentation

Post Herpetic Neuralgia Treatment Market Prevalent Opportunities upto 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Growing cases of post herpetic neuralgia treatment are increasing the number of referrals to pain Growing cases of post herpetic neuralgia treatment are increasing the number of referrals to pain  management clinics resulting in growth of market. According to a latest research by Persistence  Market Research (PMR), the global post herpetic neuralgia treatment market is anticipated to  account for over US$ 908.4 Mn, in terms of value, by 2026 end. The report on post herpetic  neuralgia treatment further projects significant growth potential of post herpetic neuralgia  treatment market with CAGR pegged at 5.3% through 2026. Post Herpetic Neuralgia Treatment Market: Segmental Overview The post herpetic neuralgia treatment market includes segments by treatment type, distribution  channels and regions. The treatment type segment of the post herpetic neuralgia treatment market  includes drugs, patches and steroid injectable. The drug segment is sub segmented by  anticonvulsants, antidepressants, and opioids. The patches segment is sub segmented by  lidocaine skin patches and capsaicin skin patches. The distribution channel segment of the post  herpetic neuralgia treatment market includes institutional sales and retail sales. The institutional  sales includes hospital pharmacies, and clinics. The retail sales includes retail sales, retail  pharmacies, drug stores and mail order pharmacies. Based on the treatment type, the drugs segment accounts for the largest share of the post herpetic 

  2. neuralgia treatment market with a share of 80.9 % in 2018. However the patches segment is neuralgia treatment market with a share of 80.9 % in 2018. However the patches segment is  expected to grow at the highest CAGR of 5.6 during the forecast period. Post Herpetic Neuralgia Treatment Market: Factors Impacting Revenue Growth The growth of the global post herpetic neuralgia treatment market is primarily driven by growing  prevalence of post herpetic neuralgia and geriatric population. The development of healthcare  infrastructure around the world coupled with the governmental support to post herpetic neuralgia  treatment products is also expected to drive the growth of the post herpetic neuralgia treatment  market. However, the poor efficacy and efficiency of present post herpetic neuralgia treatment  drugs are factors expected to hamper the growth of the post herpetic neuralgia treatment market.  The companies operating in the post herpetic neuralgia treatment are involved in developing new  experimental drugs. However concerns over opioid use and the growing mortality from overdose are the prime  constraints on the post herpetic neuralgia treatment market. Opioid overdose deaths account for  49,000 of the 72,000 drug overdose deaths in the USA in 2017. According to the center of  disease control, around 66% of the more than 63,600 drug overdose deaths in 2016 involved an  opioid and on average, 115 Americans die every day from an opioid overdose. The lack of  definite curative treatment and the poor efficacy and efficiency of drugs is also hampering the  post herpetic neuralgia treatment market growth. For Detailed Insights On Enhancing Your Product Footprint, Request For A Sample Here  @ https://www.persistencemarketresearch.com/samples/14506 This post herpetic neuralgia treatment report assesses the trends that are driving the growth of  each segment of the post herpetic neuralgia treatment market on the global as well as regional  level, and offers potential takeaways that could prove substantially useful for manufacturers  planning to enter the post herpetic neuralgia treatment market. Post Herpetic Neuralgia Treatment Market: Regional Insights North America is expected to be the dominant regional market for post herpetic neuralgia  treatment, accounting for a high revenue share in 2017. The U.S post herpetic neuralgia  treatment market is expected to account for a large share and to grow at a CAGR of 4.4 % over  the forecast period, while Canada is expected to register a CAGR of 5.2%. Europe and Asia  Pacific post herpetic neuralgia treatment markets collectively are expected to grow at CAGRs of  4.6 % and 6.0 %, respectively. The post herpetic neuralgia treatment market is expected to shift  in favour of developing regions led by China owing to its fast developing economy and  healthcare infrastructure. Revenue from the post herpetic neuralgia treatment market in countries  of Asia Pacific such as China is expected to expand at the relatively higher CAGR due to  developing economy, advancing healthcare infrastructure which reflects a high post herpetic 

  3. neuralgia treatment market equity. The Middle East and Africa post herpetic neuralgia treatment market is dominated by the gulf  economies owing to their high per capita income and high public healthcare expenditure. The  development of large hospital complex in the Gulf nations is driving a large market adoption of  post herpetic neuralgia treatment products. To Get Extensive Insights On Key Trends, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/14506 Post Herpetic Neuralgia Treatment Market: Competitive Landscape PMR’s report tracks some of the key companies operating in the post herpetic neuralgia  treatment market, such as Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Endo  Pharmaceuticals Inc., Daiichi Sankyo, Acorda Therapeutics, Purdue Pharma L.P, Teikoku  Pharma USA, Inc., Janssen Pharmaceuticals, Inc. among others. The companies perating in the  post herpetic neuralgia treatment market are focusing on developing new drugs for post herpetic  neuralgia treatment.  There is a lack of effective and curative post herpetic neuralgia treatment. Symptomatic  treatment is the chief goal of treatment as there is no treatment for PHN. Calcium-channel  blockers such as gabapentin and pregabalin are first line agents in the treatment of PHN.  Concerns over opioid use and the growing mortality from overdose are the prime constraints on  the post herpetic neuralgia treatment market.

More Related